Recently Featured

Personalized Cartilage Graft Developed for Life-Threatening Infant Airway Narrowing

June 20, 2026
A study led by researchers at Children’s Hospital of Philadelphia (CHOP) has introduced a groundbreaking method using decellularized cartilage combined with patient-specific cells to address severe subglottic stenosis (SGS) in infants. This condition, which affects approximately 20,000 infants annually, results in airway narrowing that can necessitate complex surgical interventions. The research demonstrates that this innovative…

CDER Collaborates with Public-Private Partnerships to Address Drug Development Gaps

June 20, 2026
The Center for Drug Evaluation and Research (CDER) is actively engaging in scientific public-private partnerships and consortia to identify and bridge critical gaps in drug development. This initiative underscores the increasing recognition of collaborative efforts in enhancing the efficiency and effectiveness of the drug approval process. By leveraging diverse expertise from both public and private…

NIH Diversity Programs Doubled Undergraduates’ Odds of Earning a Ph.D., 20-Year Study Reveals

June 19, 2026
A recent 20-year study published in the journal Science Advances has revealed that two diversity-oriented programs supported by the National Institutes of Health (NIH) significantly increased the likelihood of undergraduate students earning a Ph.D. The findings indicate that participation in these programs doubled the odds of achieving this advanced degree, highlighting the effectiveness of targeted…

Understanding the Investigational New Drug (IND) Application Process

June 19, 2026
The Investigational New Drug (IND) application is a critical step in the drug development process, allowing sponsors to begin clinical trials in humans. This application must adhere to stringent regulations set forth by the FDA, ensuring that the proposed investigational drug is safe for initial use in clinical settings. The IND process encompasses various types,…

Ongoing Cases